4//SEC Filing
TOMSICEK MICHAEL JOHN 4
Accession 0000905148-25-002174
CIK 0001781174other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 5:57 PM ET
Size
16.9 KB
Accession
0000905148-25-002174
Insider Transaction Report
Form 4
TOMSICEK MICHAEL JOHN
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-13+20,275→ 20,275 totalExercise: $1.20Exp: 2035-06-12→ Common Stock (20,275 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest on the date immediately preceding the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service through the applicable vesting date.
Documents
Issuer
Acrivon Therapeutics, Inc.
CIK 0001781174
Entity typeother
Related Parties
1- filerCIK 0001570392
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 5:57 PM ET
- Size
- 16.9 KB